UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
New research review suggests that post-stroke fatigue is a symptom independent of depression, pain and sleep problems, and may depend on the 'excitability' of the movement part of the brain.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
Vascular dementia is the 2nd leading cause of dementia in the UK and there are currently no proven treatments. A new study at the University of Southampton is now investigating whether a failure of fluid drainage along the walls of blood vessels in the brain is a cause of vascular dementia.
We anticipate a shortfall of £1.5 million in our funding programme this year to resume current research and support vital new projects. This could have a catastrophic knock-on effect for stroke research and delay access to important new life-changing treatments that allow people to rebuild their lives after stroke.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
About 80% of strokes are caused by a blocked blood vessel. One third of these patients have a blockage of a large blood vessel in the neck or brain known as large artery occlusion stroke (LAOS).
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
Raconteur is a publishing house and agency which produces special reports and commentary for the Times and Sunday Times.
Published on Saturday 9 May 2015, the 'Understanding Stroke 2015' report consists of a number articles covering different areas of current stroke news.